Skip to main content

Enyedy Mark J's Form 4 filing

ImmunoGen, Inc.IMGN · filed Aug 4, 2023

Accession no.
0001415889-23-011881
Filed
Aug 4, 2023
Trade date
Aug 2-4, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 10 non-derivative transactions and 7 derivative transactions. Open-market sales total $51.1M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Enyedy Mark JCIK 0001586965Director, Officer (CHIEF EXECUTIVE OFFICER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 2, 2023Common StockMOption exerciseAcquired+995,157$4.55+$4,527,964.351,436,606Direct
Aug 2, 2023Common StockSSaleDisposed−986,521$17.45F1−$17,214,791.45450,085Direct
Aug 2, 2023Common StockSSaleDisposed−8,636$18.15−$156,743.4441,449Direct
Aug 3, 2023Common StockMOption exerciseAcquired+2,760$5.25+$14,490444,209Direct
Aug 3, 2023Common StockMOption exerciseAcquired+1,017,240$4.55+$4,628,4421,461,449Direct
Aug 3, 2023Common StockSSaleDisposed−1,020,000$16.61F2−$16,942,200441,449Direct
Aug 4, 2023Common StockMOption exerciseAcquired+782,240$5.25+$4,106,7601,223,689Direct
Aug 4, 2023Common StockMOption exerciseAcquired+21,978$4.55+$99,999.91,245,667Direct
Aug 4, 2023Common StockMOption exerciseAcquired+300,000$5.65+$1,695,0001,545,667Direct
Aug 4, 2023Common StockSSaleDisposed−992,397$16.96F3−$16,831,053.12553,270Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 2, 2023Common StockMOption exerciseDisposed−995,157$0.00$0382,968Direct
Aug 3, 2023Common StockMOption exerciseDisposed−2,760$0.00$0782,240Direct
Aug 3, 2023Common StockMOption exerciseDisposed−831,147$0.00$0218,853Direct
Aug 3, 2023Common StockMOption exerciseDisposed−186,093$0.00$0196,875Direct
Aug 4, 2023Common StockMOption exerciseDisposed−300,000$0.00$00Direct
Aug 4, 2023Common StockMOption exerciseDisposed−782,240$0.00$00Direct
Aug 4, 2023Common StockMOption exerciseDisposed−21,978$0.00$0196,875Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.14 to $18.11, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges.

Referenced by the price of 1 transaction in Table I.

F2

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.50 to $17.01, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges.

Referenced by the price of 1 transaction in Table I.

F3

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.65 to $17.17, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)